Health
Nanobodies inhibit SARS-CoV-2 infection, including emergent variants – Phys.org
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
The discovery paves the way for further investigations into nanobody-based treatments for COVID-19.
Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute.
Using alpaca ‘nanobodies’…
-
General22 hours agoCoalition seeks to rebuild ties with Indian community
-
Business21 hours agoHow to retire in your 50s with ASX shares
-
General22 hours agoFood and garden organic waste bin system on verge of collapse across WA’s South West
-
Noosa News23 hours agoNational Drought Forum convenes in SA to put policy under scrutiny